Read the latest RCOphth news updates and guidance here.
In the second episode of “The Congress that wasn’t" Christina Rennie chairs her session entitled controversies in diabetic retinopathy. We also talk to Ketan Kapoor, Meriam Islam and Aidan Benson, three abstract holders, about their work.
In 'The Congress that wasn’t' episode 1, we hear from Professor Andrew Lotery who talked about the VICI study which evaluated the use of Eplerenone as a treatment for chronic central serous retinopathy (CSCR). We then spoke with, Conor Lyons, Anna Song and Jasna Astalos, three abstract holders, about their work.
In this episode we spoke with Hani Hasan, an Ophthalmologist at the Great Western Hospital in Swindon. We talked his work related to the prediction and early identification of hydroxychloroquine maculopathy.
Ophthalmologists make use of micro-surgical techniques in a variety of operations on the eye. The use of EyeSi simulators to practice these techniques allows trainees to refresh and improve their surgical skills.
As the current situation with COVID-19 changes we are closely monitoring the impact on the RCOphth, its staff and members. Staff are working from home and will continue to provide services to our membership and the wider eye health community.
In this episode we speak with Mr. Mike Burdon, the current president of the Royal College of Ophthalmologists and Mr. Bernie Chang, the incoming and newly elected president of our college.
In this episode, Aman Chandra, a consultant vitreo-retinal surgeon and the Awards and Scholarships Lead at the college spoke with Professor Mario Romano, a vitreo-retinal surgeon working in the epicentre of the European COVID19 crisis in Milan.
Emergency eye care services have seen large increases in demand over the last 10 years, with over 500,000 cases recorded in England in 2018-2019. Many common (urgent and minor) acute eye conditions, are not sight or life threatening and can be managed safely outside of the emergency care setting.
The COVID-19 response is likely to move beyond full lockdown soon, and many hospitals are examining how they can restart some services safely.
The UK has been experiencing a shortage of mitomycin 2mg, 10mg, 20mg vials for intravenous administration and 40mg for intravesical administration since late October 2019. Since the recall of Kyowa Kirin product in early November 2019 all Trusts have had to rely on unlicensed imports. Kyowa Kirin have withdrawn their marketing authorisation for Mitomycin-C and have no immediate plans to return to market with this product range.
